| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lassa Fever | 23 | 2024 | 97 | 6.380 |
Why?
|
| Lassa virus | 22 | 2024 | 97 | 5.170 |
Why?
|
| Ebolavirus | 28 | 2023 | 263 | 4.960 |
Why?
|
| Genome, Viral | 27 | 2022 | 667 | 4.500 |
Why?
|
| Hemorrhagic Fever, Ebola | 30 | 2023 | 428 | 4.490 |
Why?
|
| Selection, Genetic | 30 | 2014 | 914 | 3.110 |
Why?
|
| Viruses | 7 | 2023 | 374 | 2.570 |
Why?
|
| Disease Outbreaks | 24 | 2023 | 1772 | 2.160 |
Why?
|
| Metagenomics | 7 | 2023 | 428 | 2.000 |
Why?
|
| RNA, Viral | 22 | 2021 | 2902 | 1.850 |
Why?
|
| Evolution, Molecular | 20 | 2024 | 1940 | 1.760 |
Why?
|
| Metagenome | 7 | 2021 | 418 | 1.680 |
Why?
|
| Biological Evolution | 14 | 2021 | 1076 | 1.600 |
Why?
|
| Phylogeny | 24 | 2023 | 2803 | 1.470 |
Why?
|
| Capsid | 2 | 2022 | 436 | 1.390 |
Why?
|
| Genome, Human | 17 | 2023 | 4420 | 1.380 |
Why?
|
| Babesia microti | 2 | 2019 | 31 | 1.220 |
Why?
|
| Genetic Variation | 30 | 2022 | 6544 | 1.210 |
Why?
|
| Plasmodium falciparum | 19 | 2020 | 1732 | 1.210 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2023 | 1366 | 1.200 |
Why?
|
| RNA Viruses | 3 | 2019 | 124 | 1.190 |
Why?
|
| DNA Barcoding, Taxonomic | 4 | 2019 | 136 | 1.160 |
Why?
|
| Contact Tracing | 4 | 2022 | 273 | 1.150 |
Why?
|
| Babesiosis | 2 | 2019 | 92 | 1.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 10 | 2021 | 3597 | 1.090 |
Why?
|
| Epitopes, T-Lymphocyte | 5 | 2023 | 880 | 1.070 |
Why?
|
| Nucleic Acids | 3 | 2023 | 182 | 1.050 |
Why?
|
| Open Reading Frames | 3 | 2021 | 810 | 1.030 |
Why?
|
| Isovaleryl-CoA Dehydrogenase | 1 | 2024 | 4 | 0.980 |
Why?
|
| Hemorrhagic Fevers, Viral | 4 | 2023 | 24 | 0.950 |
Why?
|
| Genetic Techniques | 4 | 2016 | 435 | 0.910 |
Why?
|
| Sierra Leone | 15 | 2021 | 166 | 0.890 |
Why?
|
| Meningitis | 2 | 2021 | 216 | 0.880 |
Why?
|
| Polymorphism, Single Nucleotide | 38 | 2021 | 15519 | 0.870 |
Why?
|
| Virus Diseases | 3 | 2020 | 711 | 0.860 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2024 | 167 | 0.860 |
Why?
|
| Dengue Virus | 3 | 2021 | 204 | 0.840 |
Why?
|
| Haplotypes | 25 | 2020 | 2779 | 0.840 |
Why?
|
| Antibodies, Viral | 17 | 2022 | 3176 | 0.830 |
Why?
|
| Nigeria | 20 | 2023 | 733 | 0.830 |
Why?
|
| Macaca | 2 | 2022 | 440 | 0.810 |
Why?
|
| Genome, Protozoan | 5 | 2016 | 142 | 0.810 |
Why?
|
| Edar Receptor | 4 | 2016 | 24 | 0.800 |
Why?
|
| Diagnostic Test Approval | 1 | 2021 | 2 | 0.790 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2014 | 157 | 0.790 |
Why?
|
| Africa, Western | 13 | 2023 | 154 | 0.790 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2021 | 39 | 0.790 |
Why?
|
| Encephalitis | 2 | 2021 | 423 | 0.760 |
Why?
|
| Genomics | 16 | 2023 | 5720 | 0.750 |
Why?
|
| Nucleocapsid Proteins | 2 | 2020 | 77 | 0.740 |
Why?
|
| Directed Molecular Evolution | 1 | 2021 | 160 | 0.740 |
Why?
|
| Mumps virus | 1 | 2020 | 24 | 0.740 |
Why?
|
| DNA, Protozoan | 5 | 2015 | 237 | 0.720 |
Why?
|
| Virus Release | 1 | 2020 | 39 | 0.710 |
Why?
|
| Dependovirus | 2 | 2022 | 706 | 0.710 |
Why?
|
| 3' Untranslated Regions | 1 | 2021 | 513 | 0.690 |
Why?
|
| Mumps | 1 | 2020 | 64 | 0.690 |
Why?
|
| Dengue | 3 | 2021 | 256 | 0.690 |
Why?
|
| Malaria, Falciparum | 8 | 2020 | 1077 | 0.670 |
Why?
|
| Polymerase Chain Reaction | 8 | 2021 | 6171 | 0.650 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2018 | 34 | 0.620 |
Why?
|
| Disease | 2 | 2021 | 680 | 0.620 |
Why?
|
| Epidemiology | 1 | 2020 | 287 | 0.610 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 40 | 0.610 |
Why?
|
| Humans | 180 | 2024 | 744343 | 0.600 |
Why?
|
| RNA Stability | 1 | 2019 | 321 | 0.600 |
Why?
|
| Genes, Reporter | 3 | 2021 | 1547 | 0.600 |
Why?
|
| Enzyme Assays | 1 | 2018 | 111 | 0.590 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 365 | 0.590 |
Why?
|
| Molecular Epidemiology | 7 | 2021 | 468 | 0.590 |
Why?
|
| Laboratories | 1 | 2021 | 463 | 0.580 |
Why?
|
| Genome-Wide Association Study | 10 | 2024 | 12261 | 0.580 |
Why?
|
| Fungi | 1 | 2019 | 327 | 0.570 |
Why?
|
| Alleles | 16 | 2021 | 6933 | 0.560 |
Why?
|
| Genetics, Population | 13 | 2014 | 934 | 0.560 |
Why?
|
| Sequence Analysis, RNA | 7 | 2020 | 2012 | 0.550 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2020 | 828 | 0.550 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 1224 | 0.550 |
Why?
|
| Hair | 3 | 2016 | 483 | 0.550 |
Why?
|
| Gene Targeting | 1 | 2019 | 880 | 0.540 |
Why?
|
| Endonucleases | 2 | 2018 | 380 | 0.530 |
Why?
|
| RNA, Protozoan | 1 | 2015 | 43 | 0.530 |
Why?
|
| Peptides | 3 | 2023 | 4409 | 0.520 |
Why?
|
| Gene Frequency | 21 | 2016 | 3588 | 0.490 |
Why?
|
| Information Theory | 1 | 2014 | 51 | 0.490 |
Why?
|
| Zoonoses | 4 | 2023 | 185 | 0.490 |
Why?
|
| Coronavirus Infections | 5 | 2020 | 3133 | 0.480 |
Why?
|
| Sequence Analysis, DNA | 16 | 2020 | 4803 | 0.480 |
Why?
|
| Mutation | 23 | 2023 | 29786 | 0.470 |
Why?
|
| Public Health | 4 | 2023 | 2603 | 0.470 |
Why?
|
| Amino Acids | 1 | 2020 | 1736 | 0.460 |
Why?
|
| Antigens, Viral | 9 | 2021 | 1035 | 0.450 |
Why?
|
| Exocrine Glands | 1 | 2013 | 50 | 0.450 |
Why?
|
| Single-Cell Analysis | 3 | 2021 | 2183 | 0.440 |
Why?
|
| Bacteria | 3 | 2019 | 2114 | 0.440 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 3240 | 0.440 |
Why?
|
| Plasmodium vivax | 1 | 2015 | 208 | 0.440 |
Why?
|
| Data Interpretation, Statistical | 2 | 2014 | 2716 | 0.440 |
Why?
|
| Malaria, Vivax | 1 | 2015 | 173 | 0.440 |
Why?
|
| Benchmarking | 1 | 2019 | 1042 | 0.430 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 2021 | 171 | 0.430 |
Why?
|
| Antimalarials | 3 | 2020 | 905 | 0.420 |
Why?
|
| Computer Simulation | 6 | 2020 | 6196 | 0.420 |
Why?
|
| HEK293 Cells | 5 | 2021 | 4204 | 0.410 |
Why?
|
| Access to Information | 1 | 2015 | 320 | 0.400 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2016 | 587 | 0.400 |
Why?
|
| Animals | 47 | 2024 | 168757 | 0.400 |
Why?
|
| Encephalitis Virus, California | 2 | 2020 | 8 | 0.390 |
Why?
|
| Cholera | 3 | 2013 | 785 | 0.390 |
Why?
|
| Proteome | 1 | 2021 | 1799 | 0.390 |
Why?
|
| Visual Cortex | 1 | 2019 | 1149 | 0.390 |
Why?
|
| Bioethics | 1 | 2012 | 116 | 0.370 |
Why?
|
| Drug Resistance | 4 | 2020 | 1609 | 0.370 |
Why?
|
| Culicidae | 3 | 2020 | 105 | 0.370 |
Why?
|
| Linkage Disequilibrium | 14 | 2013 | 1997 | 0.370 |
Why?
|
| Primates | 3 | 2022 | 545 | 0.350 |
Why?
|
| Malaria | 5 | 2024 | 1239 | 0.340 |
Why?
|
| Software | 6 | 2019 | 4443 | 0.340 |
Why?
|
| Seroepidemiologic Studies | 3 | 2024 | 401 | 0.340 |
Why?
|
| Genetic Loci | 5 | 2020 | 2575 | 0.330 |
Why?
|
| HLA Antigens | 4 | 2023 | 1381 | 0.330 |
Why?
|
| Transgenes | 2 | 2022 | 1009 | 0.320 |
Why?
|
| Quantitative Trait Loci | 6 | 2021 | 2019 | 0.320 |
Why?
|
| Health Policy | 1 | 2021 | 2661 | 0.320 |
Why?
|
| Virion | 3 | 2020 | 433 | 0.320 |
Why?
|
| Gene Expression Regulation | 7 | 2024 | 12072 | 0.320 |
Why?
|
| Death | 1 | 2013 | 678 | 0.320 |
Why?
|
| Genotype | 18 | 2023 | 12951 | 0.310 |
Why?
|
| Recombination, Genetic | 7 | 2021 | 1586 | 0.310 |
Why?
|
| Statistics as Topic | 1 | 2014 | 2373 | 0.310 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.300 |
Why?
|
| Filoviridae | 2 | 2019 | 16 | 0.300 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 3848 | 0.300 |
Why?
|
| Genome, Bacterial | 1 | 2012 | 760 | 0.300 |
Why?
|
| Interleukins | 1 | 2012 | 791 | 0.300 |
Why?
|
| Amino Acid Sequence | 8 | 2024 | 13815 | 0.300 |
Why?
|
| Plasmodium | 2 | 2024 | 250 | 0.290 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 4479 | 0.290 |
Why?
|
| Eccrine Glands | 2 | 2018 | 45 | 0.290 |
Why?
|
| Species Specificity | 6 | 2021 | 2478 | 0.290 |
Why?
|
| Africa | 6 | 2022 | 673 | 0.290 |
Why?
|
| CD40 Ligand | 3 | 2003 | 526 | 0.280 |
Why?
|
| Information Dissemination | 1 | 2015 | 1099 | 0.280 |
Why?
|
| Pyruvate Kinase | 1 | 2008 | 189 | 0.280 |
Why?
|
| Viral Envelope Proteins | 3 | 2020 | 635 | 0.280 |
Why?
|
| Computational Biology | 5 | 2019 | 3521 | 0.280 |
Why?
|
| Models, Animal | 1 | 2013 | 2171 | 0.270 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4931 | 0.270 |
Why?
|
| Disease Reservoirs | 3 | 2018 | 131 | 0.270 |
Why?
|
| Pandemics | 8 | 2022 | 8388 | 0.270 |
Why?
|
| Base Sequence | 11 | 2015 | 12797 | 0.270 |
Why?
|
| Models, Genetic | 9 | 2021 | 3494 | 0.270 |
Why?
|
| Fever | 4 | 2024 | 1616 | 0.270 |
Why?
|
| Brain | 5 | 2023 | 26385 | 0.260 |
Why?
|
| Disaster Planning | 2 | 2022 | 549 | 0.260 |
Why?
|
| Blood | 3 | 2018 | 598 | 0.260 |
Why?
|
| Biomedical Research | 3 | 2016 | 3309 | 0.260 |
Why?
|
| Hair Follicle | 2 | 2018 | 209 | 0.260 |
Why?
|
| Gene Expression | 5 | 2024 | 7799 | 0.250 |
Why?
|
| Nucleoproteins | 3 | 2020 | 115 | 0.250 |
Why?
|
| Gonorrhea | 2 | 2023 | 335 | 0.250 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 9438 | 0.250 |
Why?
|
| Macaca mulatta | 5 | 2023 | 2375 | 0.240 |
Why?
|
| Immunoassay | 4 | 2018 | 752 | 0.240 |
Why?
|
| Sequence Deletion | 3 | 2023 | 1526 | 0.240 |
Why?
|
| Vocalization, Animal | 1 | 2024 | 87 | 0.230 |
Why?
|
| Borrelia | 1 | 2024 | 67 | 0.230 |
Why?
|
| Databases, Nucleic Acid | 2 | 2015 | 211 | 0.230 |
Why?
|
| Guinea | 4 | 2016 | 41 | 0.230 |
Why?
|
| Histocompatibility Antigens | 2 | 2023 | 471 | 0.230 |
Why?
|
| Viral Proteins | 4 | 2020 | 1900 | 0.230 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 497 | 0.230 |
Why?
|
| Metabolic Diseases | 3 | 2020 | 658 | 0.220 |
Why?
|
| Mental Disorders | 1 | 2023 | 6600 | 0.220 |
Why?
|
| Immunity, Innate | 5 | 2022 | 2958 | 0.220 |
Why?
|
| Mice | 9 | 2023 | 81183 | 0.220 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2021 | 794 | 0.220 |
Why?
|
| Genetic Markers | 4 | 2019 | 2634 | 0.220 |
Why?
|
| Male | 50 | 2022 | 350118 | 0.210 |
Why?
|
| Pan troglodytes | 2 | 2018 | 229 | 0.210 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2020 | 602 | 0.210 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2023 | 165 | 0.210 |
Why?
|
| Epidemics | 3 | 2018 | 523 | 0.210 |
Why?
|
| Polyribosomes | 1 | 2021 | 110 | 0.200 |
Why?
|
| Borrelia burgdorferi | 1 | 2023 | 180 | 0.200 |
Why?
|
| Amino Acid Substitution | 3 | 2016 | 1791 | 0.200 |
Why?
|
| Chromosome Mapping | 6 | 2015 | 4740 | 0.200 |
Why?
|
| Oxidoreductases | 1 | 2024 | 424 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2021 | 66 | 0.200 |
Why?
|
| Ochlerotatus | 1 | 2020 | 4 | 0.200 |
Why?
|
| Encephalitis, California | 1 | 2020 | 4 | 0.200 |
Why?
|
| Female | 50 | 2023 | 380194 | 0.190 |
Why?
|
| Genetic Fitness | 1 | 2022 | 121 | 0.190 |
Why?
|
| Sequence Analysis | 1 | 2021 | 256 | 0.190 |
Why?
|
| Adaptation, Physiological | 4 | 2018 | 1312 | 0.190 |
Why?
|
| Drug Resistance, Viral | 3 | 2023 | 820 | 0.190 |
Why?
|
| Polymorphism, Genetic | 8 | 2021 | 4328 | 0.190 |
Why?
|
| Basic Reproduction Number | 1 | 2020 | 31 | 0.190 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2021 | 102 | 0.190 |
Why?
|
| Sequence Alignment | 3 | 2015 | 2256 | 0.190 |
Why?
|
| Molecular Sequence Data | 14 | 2015 | 18111 | 0.190 |
Why?
|
| Conserved Sequence | 3 | 2023 | 1202 | 0.190 |
Why?
|
| Universities | 2 | 2023 | 956 | 0.180 |
Why?
|
| Iran | 1 | 2023 | 708 | 0.180 |
Why?
|
| Senegal | 5 | 2024 | 294 | 0.180 |
Why?
|
| Phylogeography | 3 | 2018 | 82 | 0.180 |
Why?
|
| Vaccination | 3 | 2021 | 3278 | 0.180 |
Why?
|
| Gene Library | 3 | 2019 | 1074 | 0.180 |
Why?
|
| Mammals | 2 | 2023 | 1143 | 0.180 |
Why?
|
| Autopsy | 2 | 2021 | 1020 | 0.180 |
Why?
|
| Filoviridae Infections | 1 | 2019 | 6 | 0.180 |
Why?
|
| Laboratories, Hospital | 1 | 2021 | 194 | 0.180 |
Why?
|
| Yellow Fever | 1 | 2020 | 53 | 0.170 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 915 | 0.170 |
Why?
|
| Virus Assembly | 1 | 2020 | 144 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2023 | 3617 | 0.170 |
Why?
|
| Ciprofloxacin | 3 | 2023 | 315 | 0.170 |
Why?
|
| Population Groups | 2 | 2010 | 209 | 0.170 |
Why?
|
| Terrorism | 1 | 2022 | 211 | 0.170 |
Why?
|
| Motor Neurons | 1 | 2024 | 844 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2017 | 17446 | 0.170 |
Why?
|
| International Cooperation | 3 | 2016 | 1420 | 0.160 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 256 | 0.160 |
Why?
|
| Artemisinins | 1 | 2020 | 221 | 0.160 |
Why?
|
| United States | 13 | 2023 | 69872 | 0.160 |
Why?
|
| Vero Cells | 1 | 2019 | 485 | 0.160 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 329 | 0.160 |
Why?
|
| Virology | 2 | 2016 | 77 | 0.160 |
Why?
|
| DNA Primers | 2 | 2021 | 2892 | 0.160 |
Why?
|
| Computer Systems | 1 | 2020 | 483 | 0.160 |
Why?
|
| Limit of Detection | 1 | 2019 | 265 | 0.160 |
Why?
|
| RNA Ligase (ATP) | 1 | 1997 | 9 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 555 | 0.160 |
Why?
|
| Prevalence | 7 | 2022 | 15226 | 0.150 |
Why?
|
| RNA, Catalytic | 1 | 1997 | 50 | 0.150 |
Why?
|
| Middle Aged | 25 | 2021 | 213383 | 0.150 |
Why?
|
| Honduras | 1 | 2017 | 36 | 0.150 |
Why?
|
| Young Adult | 19 | 2021 | 56430 | 0.150 |
Why?
|
| Influenza, Human | 2 | 2022 | 1479 | 0.150 |
Why?
|
| Genome | 5 | 2024 | 1808 | 0.150 |
Why?
|
| Lyme Disease | 1 | 2023 | 621 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2024 | 1341 | 0.150 |
Why?
|
| Phenotype | 9 | 2021 | 16365 | 0.150 |
Why?
|
| Financing, Government | 1 | 2021 | 468 | 0.150 |
Why?
|
| HIV | 2 | 2020 | 1604 | 0.150 |
Why?
|
| Algorithms | 5 | 2021 | 13881 | 0.150 |
Why?
|
| MicroRNAs | 3 | 2020 | 3752 | 0.140 |
Why?
|
| Antibodies, Neutralizing | 4 | 2022 | 1978 | 0.140 |
Why?
|
| Integrins | 1 | 2021 | 846 | 0.140 |
Why?
|
| South America | 2 | 2015 | 181 | 0.140 |
Why?
|
| Colombia | 1 | 2017 | 258 | 0.140 |
Why?
|
| Cytochromes b | 1 | 2016 | 36 | 0.140 |
Why?
|
| Atovaquone | 1 | 2016 | 58 | 0.140 |
Why?
|
| Endemic Diseases | 1 | 2017 | 182 | 0.140 |
Why?
|
| Influenza A virus | 1 | 2020 | 456 | 0.140 |
Why?
|
| Microvessels | 1 | 2021 | 544 | 0.140 |
Why?
|
| Motor Cortex | 1 | 2024 | 986 | 0.140 |
Why?
|
| Receptors, Ectodysplasin | 1 | 2015 | 3 | 0.140 |
Why?
|
| Ribonucleases | 1 | 2017 | 287 | 0.140 |
Why?
|
| Adult | 27 | 2021 | 214055 | 0.140 |
Why?
|
| Government Regulation | 1 | 2021 | 522 | 0.140 |
Why?
|
| Research Support as Topic | 1 | 2021 | 705 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2021 | 970 | 0.140 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2018 | 1375 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2021 | 2649 | 0.140 |
Why?
|
| Puerto Rico | 1 | 2017 | 356 | 0.140 |
Why?
|
| Viral Load | 4 | 2021 | 3299 | 0.140 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2023 | 238 | 0.140 |
Why?
|
| Ribavirin | 3 | 2014 | 395 | 0.140 |
Why?
|
| Murinae | 1 | 2015 | 18 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 847 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2019 | 2026 | 0.130 |
Why?
|
| Rhabdoviridae | 1 | 2015 | 5 | 0.130 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2018 | 323 | 0.130 |
Why?
|
| Rhabdoviridae Infections | 1 | 2015 | 8 | 0.130 |
Why?
|
| Intermediate Filament Proteins | 1 | 2016 | 269 | 0.130 |
Why?
|
| Antigen Presentation | 1 | 2021 | 1284 | 0.130 |
Why?
|
| Flaviviridae Infections | 1 | 2014 | 7 | 0.130 |
Why?
|
| GB virus C | 1 | 2014 | 9 | 0.130 |
Why?
|
| Liberia | 4 | 2016 | 167 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 2203 | 0.130 |
Why?
|
| Adolescent | 18 | 2021 | 85781 | 0.130 |
Why?
|
| Asia | 2 | 2015 | 610 | 0.130 |
Why?
|
| Semen | 1 | 2017 | 316 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.130 |
Why?
|
| Facies | 1 | 2015 | 197 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 393 | 0.130 |
Why?
|
| Azithromycin | 1 | 2016 | 196 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 14722 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 1477 | 0.130 |
Why?
|
| RNA | 2 | 2023 | 2749 | 0.130 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2016 | 156 | 0.120 |
Why?
|
| Founder Effect | 2 | 2013 | 189 | 0.120 |
Why?
|
| West Nile virus | 1 | 2015 | 82 | 0.120 |
Why?
|
| Glucosephosphate Dehydrogenase | 3 | 2009 | 207 | 0.120 |
Why?
|
| Poliovirus | 1 | 2015 | 109 | 0.120 |
Why?
|
| Dogs | 1 | 2019 | 3912 | 0.120 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2014 | 138 | 0.120 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 783 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 21827 | 0.120 |
Why?
|
| Ribosomal Proteins | 1 | 2016 | 360 | 0.120 |
Why?
|
| Genetic Drift | 1 | 2013 | 43 | 0.120 |
Why?
|
| Fossils | 1 | 2014 | 76 | 0.120 |
Why?
|
| Societies, Scientific | 1 | 2015 | 220 | 0.120 |
Why?
|
| Microcephaly | 1 | 2018 | 432 | 0.120 |
Why?
|
| Models, Statistical | 3 | 2016 | 5102 | 0.120 |
Why?
|
| HIV-1 | 2 | 2023 | 6939 | 0.110 |
Why?
|
| Vagina | 1 | 2019 | 825 | 0.110 |
Why?
|
| Databases, Genetic | 2 | 2019 | 1783 | 0.110 |
Why?
|
| Pigmentation | 1 | 2014 | 148 | 0.110 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 652 | 0.110 |
Why?
|
| Organoids | 1 | 2019 | 701 | 0.110 |
Why?
|
| Cross Reactions | 3 | 2021 | 841 | 0.110 |
Why?
|
| Kinetics | 1 | 2021 | 6473 | 0.110 |
Why?
|
| Primate Diseases | 1 | 2012 | 15 | 0.110 |
Why?
|
| World Health Organization | 1 | 2019 | 1318 | 0.110 |
Why?
|
| Receptors, LDL | 1 | 2015 | 475 | 0.110 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2013 | 39 | 0.110 |
Why?
|
| Codon | 1 | 2015 | 611 | 0.110 |
Why?
|
| Geography | 3 | 2017 | 669 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2022 | 3420 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1584 | 0.110 |
Why?
|
| Brazil | 1 | 2017 | 1270 | 0.110 |
Why?
|
| Dominican Republic | 1 | 2012 | 76 | 0.110 |
Why?
|
| Child, Preschool | 10 | 2021 | 41006 | 0.110 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 528 | 0.110 |
Why?
|
| Africa South of the Sahara | 2 | 2012 | 724 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6386 | 0.110 |
Why?
|
| Flagellin | 1 | 2013 | 125 | 0.110 |
Why?
|
| Point-of-Care Systems | 2 | 2020 | 1177 | 0.100 |
Why?
|
| Cell Separation | 1 | 2018 | 1751 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 1465 | 0.100 |
Why?
|
| Cardiology | 1 | 2023 | 1668 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2013 | 186 | 0.100 |
Why?
|
| Massachusetts | 2 | 2021 | 8663 | 0.100 |
Why?
|
| Genetic Pleiotropy | 1 | 2013 | 182 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 418 | 0.100 |
Why?
|
| Mefloquine | 1 | 2011 | 55 | 0.100 |
Why?
|
| HIV Infections | 3 | 2023 | 16718 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2015 | 513 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2020 | 1786 | 0.100 |
Why?
|
| Phenanthrenes | 1 | 2011 | 63 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2023 | 1035 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2021 | 19229 | 0.100 |
Why?
|
| K562 Cells | 2 | 2024 | 634 | 0.100 |
Why?
|
| Gambia | 3 | 2011 | 98 | 0.100 |
Why?
|
| Baseball | 1 | 2011 | 90 | 0.090 |
Why?
|
| Ethanolamines | 1 | 2011 | 158 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2015 | 593 | 0.090 |
Why?
|
| Antigens | 1 | 2016 | 1466 | 0.090 |
Why?
|
| Infant | 7 | 2023 | 35136 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15540 | 0.090 |
Why?
|
| Malaria, Cerebral | 1 | 2012 | 135 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2015 | 907 | 0.090 |
Why?
|
| Glycoproteins | 2 | 2015 | 2263 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2015 | 694 | 0.090 |
Why?
|
| Haiti | 1 | 2012 | 553 | 0.090 |
Why?
|
| Drug Resistance, Microbial | 1 | 2013 | 862 | 0.090 |
Why?
|
| Genes, Fungal | 1 | 2011 | 455 | 0.090 |
Why?
|
| Awards and Prizes | 1 | 2015 | 375 | 0.090 |
Why?
|
| Aged | 10 | 2021 | 163280 | 0.090 |
Why?
|
| Scalp | 1 | 2013 | 380 | 0.090 |
Why?
|
| Fluorenes | 1 | 2011 | 160 | 0.090 |
Why?
|
| Research Personnel | 1 | 2015 | 573 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 2119 | 0.090 |
Why?
|
| Models, Molecular | 4 | 2020 | 5456 | 0.090 |
Why?
|
| Parasites | 1 | 2012 | 163 | 0.090 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 107 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1836 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 327 | 0.090 |
Why?
|
| Multifactorial Inheritance | 2 | 2015 | 1194 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2016 | 1431 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2023 | 25625 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 1814 | 0.080 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2009 | 53 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 2025 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 133 | 0.080 |
Why?
|
| Genetics, Medical | 2 | 2014 | 338 | 0.080 |
Why?
|
| Proteins | 1 | 2024 | 6103 | 0.080 |
Why?
|
| DNA Fingerprinting | 1 | 2008 | 112 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1580 | 0.080 |
Why?
|
| Bayes Theorem | 3 | 2022 | 2309 | 0.080 |
Why?
|
| Child | 11 | 2021 | 77709 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 3846 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 19905 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 1405 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2015 | 849 | 0.080 |
Why?
|
| Immunoglobulin G | 4 | 2022 | 4560 | 0.080 |
Why?
|
| Food | 1 | 2013 | 771 | 0.080 |
Why?
|
| Myocardium | 1 | 2021 | 4776 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 1972 | 0.080 |
Why?
|
| Genetic Association Studies | 3 | 2013 | 2703 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 281 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2023 | 4256 | 0.080 |
Why?
|
| Triglycerides | 1 | 2015 | 2454 | 0.080 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 10180 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 1012 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 453 | 0.080 |
Why?
|
| Inflammation | 3 | 2022 | 10638 | 0.080 |
Why?
|
| Publishing | 1 | 2015 | 833 | 0.080 |
Why?
|
| Receptors, Virus | 2 | 2021 | 648 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2013 | 2499 | 0.070 |
Why?
|
| Community Health Services | 1 | 2012 | 650 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1547 | 0.070 |
Why?
|
| Seasons | 3 | 2023 | 1493 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2019 | 4217 | 0.070 |
Why?
|
| Obesity | 3 | 2021 | 12745 | 0.070 |
Why?
|
| Oligonucleotides | 2 | 2020 | 572 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2011 | 1252 | 0.070 |
Why?
|
| Antiporters | 1 | 2007 | 277 | 0.070 |
Why?
|
| Protein Binding | 2 | 2016 | 9386 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 2356 | 0.070 |
Why?
|
| Case-Control Studies | 8 | 2021 | 21746 | 0.070 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2005 | 43 | 0.070 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2006 | 86 | 0.070 |
Why?
|
| Population | 1 | 2006 | 142 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2008 | 767 | 0.070 |
Why?
|
| Tuberculosis | 2 | 2012 | 1912 | 0.070 |
Why?
|
| Kidney | 1 | 2021 | 7186 | 0.070 |
Why?
|
| Liver | 1 | 2021 | 7474 | 0.060 |
Why?
|
| Logistic Models | 2 | 2018 | 13408 | 0.060 |
Why?
|
| Genetic Heterogeneity | 1 | 2009 | 733 | 0.060 |
Why?
|
| Homozygote | 3 | 2007 | 1785 | 0.060 |
Why?
|
| Telomere | 1 | 2011 | 910 | 0.060 |
Why?
|
| Base Composition | 2 | 2012 | 293 | 0.060 |
Why?
|
| DNA Repair | 2 | 2013 | 2046 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 604 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 972 | 0.060 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 261 | 0.060 |
Why?
|
| Seizures | 1 | 2017 | 2859 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 906 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2007 | 936 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 2013 | 880 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8340 | 0.060 |
Why?
|
| Lactase | 1 | 2004 | 69 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12245 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2005 | 462 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 57776 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 4751 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 927 | 0.060 |
Why?
|
| Forecasting | 1 | 2013 | 2951 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2020 | 4026 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 4462 | 0.060 |
Why?
|
| Population Density | 2 | 2014 | 196 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2005 | 802 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 9274 | 0.060 |
Why?
|
| Markov Chains | 2 | 2018 | 969 | 0.060 |
Why?
|
| Chiroptera | 1 | 2024 | 107 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2023 | 1877 | 0.060 |
Why?
|
| Gene Pool | 1 | 2002 | 35 | 0.060 |
Why?
|
| Research | 1 | 2011 | 1999 | 0.060 |
Why?
|
| DNA, Viral | 2 | 2021 | 2225 | 0.050 |
Why?
|
| Caspases | 1 | 2006 | 928 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2013 | 1832 | 0.050 |
Why?
|
| Internet | 1 | 2015 | 3064 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.050 |
Why?
|
| Epitopes | 2 | 2021 | 2571 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1924 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 9856 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 669 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2023 | 77449 | 0.050 |
Why?
|
| Time Factors | 4 | 2020 | 40075 | 0.050 |
Why?
|
| Cross Protection | 1 | 2021 | 24 | 0.050 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 1941 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7659 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2021 | 53288 | 0.050 |
Why?
|
| Genes, Protozoan | 2 | 2012 | 163 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2795 | 0.050 |
Why?
|
| Immunoglobulin M | 2 | 2018 | 1537 | 0.050 |
Why?
|
| Pregnancy | 5 | 2019 | 29144 | 0.050 |
Why?
|
| Heterozygote | 2 | 2005 | 2804 | 0.050 |
Why?
|
| Fatty Acid Desaturases | 1 | 2021 | 102 | 0.050 |
Why?
|
| Bioterrorism | 1 | 2022 | 143 | 0.050 |
Why?
|
| Disease Vectors | 1 | 2020 | 60 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2020 | 1475 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2006 | 1726 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2002 | 296 | 0.050 |
Why?
|
| Biological Factors | 1 | 2022 | 164 | 0.050 |
Why?
|
| Deoxyribonuclease I | 1 | 2021 | 229 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 2752 | 0.050 |
Why?
|
| Nasopharynx | 1 | 2023 | 379 | 0.050 |
Why?
|
| Bystander Effect | 1 | 2020 | 81 | 0.050 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2020 | 107 | 0.050 |
Why?
|
| South Africa | 2 | 2019 | 1731 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2715 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2018 | 63114 | 0.050 |
Why?
|
| GATA1 Transcription Factor | 1 | 2021 | 293 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
| Hospitals, Teaching | 2 | 2017 | 1179 | 0.050 |
Why?
|
| China | 2 | 2016 | 2248 | 0.040 |
Why?
|
| Myelopoiesis | 1 | 2020 | 133 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 940 | 0.040 |
Why?
|
| Immune Sera | 1 | 2020 | 641 | 0.040 |
Why?
|
| HLA-DQ Antigens | 1 | 2020 | 210 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 236 | 0.040 |
Why?
|
| Chromosomes | 2 | 2014 | 596 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 424 | 0.040 |
Why?
|
| Adipocytes, Brown | 1 | 2020 | 144 | 0.040 |
Why?
|
| Blood Donors | 1 | 2021 | 355 | 0.040 |
Why?
|
| Cytokines | 3 | 2021 | 7322 | 0.040 |
Why?
|
| Hematuria | 1 | 2020 | 235 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 297 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2023 | 501 | 0.040 |
Why?
|
| Larynx | 1 | 2024 | 494 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 3647 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 343 | 0.040 |
Why?
|
| New England | 1 | 2022 | 1022 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 841 | 0.040 |
Why?
|
| Travel | 2 | 2017 | 788 | 0.040 |
Why?
|
| Survivors | 2 | 2020 | 2291 | 0.040 |
Why?
|
| Boston | 2 | 2023 | 9313 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2020 | 569 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2009 | 5867 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.040 |
Why?
|
| DNA | 2 | 2023 | 7301 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 2019 | 427 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2008 | 2455 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2020 | 442 | 0.040 |
Why?
|
| Demography | 2 | 2014 | 1656 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 675 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 751 | 0.040 |
Why?
|
| Plasmids | 1 | 2023 | 2307 | 0.040 |
Why?
|
| Validation Studies as Topic | 1 | 2018 | 159 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2005 | 1222 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2005 | 2751 | 0.040 |
Why?
|
| Proteinuria | 1 | 2020 | 658 | 0.040 |
Why?
|
| Templates, Genetic | 1 | 1997 | 211 | 0.040 |
Why?
|
| Biological Assay | 1 | 2020 | 652 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2021 | 743 | 0.040 |
Why?
|
| Cheirogaleidae | 1 | 2016 | 9 | 0.040 |
Why?
|
| Homeostasis | 2 | 2020 | 3340 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 970 | 0.040 |
Why?
|
| Rodentia | 1 | 2018 | 261 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 933 | 0.040 |
Why?
|
| Interferons | 1 | 2020 | 706 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2017 | 194 | 0.040 |
Why?
|
| Workflow | 1 | 2021 | 847 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2018 | 40561 | 0.040 |
Why?
|
| Arenavirus | 1 | 2016 | 7 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2018 | 302 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2022 | 6459 | 0.040 |
Why?
|
| Callithrix | 1 | 2016 | 93 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2014 | 10252 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2020 | 1005 | 0.040 |
Why?
|
| Pedigree | 3 | 2009 | 4644 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 598 | 0.040 |
Why?
|
| Aedes | 1 | 2017 | 100 | 0.030 |
Why?
|
| Microfluidics | 1 | 2022 | 662 | 0.030 |
Why?
|
| Climate | 1 | 2017 | 147 | 0.030 |
Why?
|
| Neoplasms | 2 | 2023 | 21683 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2021 | 2008 | 0.030 |
Why?
|
| Age Factors | 3 | 2021 | 18370 | 0.030 |
Why?
|
| Blood Cells | 1 | 2018 | 309 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 435 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 711 | 0.030 |
Why?
|
| Mali | 1 | 2015 | 44 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2015 | 203 | 0.030 |
Why?
|
| Age Distribution | 1 | 2021 | 2902 | 0.030 |
Why?
|
| Genetic Linkage | 2 | 2013 | 2421 | 0.030 |
Why?
|
| Ectoderm | 1 | 2015 | 137 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2016 | 311 | 0.030 |
Why?
|
| Viral Vaccines | 1 | 2021 | 636 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1017 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 2104 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 1028 | 0.030 |
Why?
|
| Democratic Republic of the Congo | 1 | 2014 | 88 | 0.030 |
Why?
|
| Viral Core Proteins | 1 | 2015 | 162 | 0.030 |
Why?
|
| Vibrio cholerae | 2 | 2013 | 806 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2015 | 151 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2020 | 827 | 0.030 |
Why?
|
| Protective Clothing | 1 | 2015 | 102 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2020 | 2088 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 23338 | 0.030 |
Why?
|
| Gene Conversion | 1 | 2014 | 71 | 0.030 |
Why?
|
| Eye Color | 1 | 2014 | 36 | 0.030 |
Why?
|
| Lactose Intolerance | 1 | 2014 | 27 | 0.030 |
Why?
|
| International Agencies | 1 | 2015 | 240 | 0.030 |
Why?
|
| Skeleton | 1 | 2014 | 30 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 791 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2015 | 718 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2016 | 1095 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1997 | 913 | 0.030 |
Why?
|
| Tibet | 1 | 2013 | 11 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 1903 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2023 | 1715 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.030 |
Why?
|
| History, Ancient | 1 | 2014 | 212 | 0.030 |
Why?
|
| Mongolia | 1 | 2013 | 91 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1348 | 0.030 |
Why?
|
| Rivers | 1 | 2013 | 66 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11483 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2013 | 100 | 0.030 |
Why?
|
| England | 1 | 2014 | 522 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 1723 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2440 | 0.030 |
Why?
|
| Virulence | 1 | 2016 | 1333 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 465 | 0.030 |
Why?
|
| Agriculture | 1 | 2014 | 190 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2013 | 23403 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 4011 | 0.030 |
Why?
|
| Leptin | 1 | 2020 | 1599 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1990 | 0.030 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2012 | 83 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2934 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2015 | 544 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 1126 | 0.030 |
Why?
|
| Binding Sites | 2 | 2011 | 6114 | 0.030 |
Why?
|
| Mucins | 1 | 2015 | 564 | 0.030 |
Why?
|
| Probability | 1 | 1997 | 2505 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2016 | 1539 | 0.030 |
Why?
|
| Skin Pigmentation | 1 | 2014 | 282 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2012 | 106 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7181 | 0.020 |
Why?
|
| Antiviral Agents | 2 | 2015 | 2987 | 0.020 |
Why?
|
| Pseudogenes | 1 | 2011 | 113 | 0.020 |
Why?
|
| Vomiting | 1 | 2014 | 636 | 0.020 |
Why?
|
| Internationality | 1 | 2017 | 1003 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2004 | 3444 | 0.020 |
Why?
|
| Parasitemia | 1 | 2012 | 174 | 0.020 |
Why?
|
| Health | 1 | 2014 | 394 | 0.020 |
Why?
|
| Insect Vectors | 1 | 2011 | 134 | 0.020 |
Why?
|
| Monocytes | 1 | 2020 | 2596 | 0.020 |
Why?
|
| DNA Polymerase beta | 1 | 2010 | 20 | 0.020 |
Why?
|
| Malawi | 1 | 2012 | 282 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3586 | 0.020 |
Why?
|
| Adiposity | 1 | 2020 | 1807 | 0.020 |
Why?
|
| Gestational Age | 1 | 2019 | 3493 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2916 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5974 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 780 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2015 | 878 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2021 | 4161 | 0.020 |
Why?
|
| Heterosexuality | 1 | 2012 | 276 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2016 | 5021 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2012 | 281 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 434 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2010 | 193 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 1438 | 0.020 |
Why?
|
| Exons | 2 | 2006 | 2437 | 0.020 |
Why?
|
| Endodeoxyribonucleases | 1 | 2010 | 165 | 0.020 |
Why?
|
| Nucleotides | 1 | 2012 | 464 | 0.020 |
Why?
|
| Fetal Death | 1 | 2011 | 448 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2020 | 2899 | 0.020 |
Why?
|
| Eye | 1 | 2013 | 729 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 1420 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3690 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 1470 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2011 | 571 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2459 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2013 | 495 | 0.020 |
Why?
|
| Glucose | 1 | 2020 | 4397 | 0.020 |
Why?
|
| Virus Replication | 1 | 2016 | 2534 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3479 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6622 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 4149 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1708 | 0.020 |
Why?
|
| Heart | 1 | 2021 | 4467 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3870 | 0.020 |
Why?
|
| Diarrhea | 1 | 2014 | 1348 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3679 | 0.020 |
Why?
|
| Incidence | 2 | 2017 | 20947 | 0.020 |
Why?
|
| Valine | 1 | 2009 | 413 | 0.020 |
Why?
|
| Central America | 1 | 2006 | 68 | 0.020 |
Why?
|
| Bangladesh | 1 | 2009 | 687 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3864 | 0.020 |
Why?
|
| Europe | 2 | 2005 | 3339 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
| Caspase 12 | 1 | 2006 | 11 | 0.020 |
Why?
|
| Methionine | 1 | 2009 | 590 | 0.020 |
Why?
|
| Cholesterol | 1 | 2015 | 2917 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4186 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 2007 | 153 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2915 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15997 | 0.020 |
Why?
|
| Disease Transmission, Infectious | 1 | 2011 | 547 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 2839 | 0.020 |
Why?
|
| Amygdalin | 1 | 2005 | 1 | 0.020 |
Why?
|
| Arbutin | 1 | 2005 | 3 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 594 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5655 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2007 | 645 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2006 | 127 | 0.020 |
Why?
|
| Utah | 1 | 2005 | 126 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 326 | 0.020 |
Why?
|
| Benzyl Alcohols | 1 | 2005 | 29 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3768 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3505 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 13033 | 0.020 |
Why?
|
| Time | 1 | 2007 | 542 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
| Glycosides | 1 | 2005 | 107 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10481 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 2012 | 1240 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2021 | 12720 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 1988 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5137 | 0.010 |
Why?
|
| Mortality | 1 | 2014 | 2864 | 0.010 |
Why?
|
| Acetylation | 1 | 2006 | 1085 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 25043 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
| Genes | 1 | 2006 | 1893 | 0.010 |
Why?
|
| Glucosides | 1 | 2005 | 451 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 72290 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9849 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14557 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7729 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12959 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3462 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3703 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2006 | 1349 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7722 | 0.010 |
Why?
|
| Family | 1 | 2007 | 3147 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 5987 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 5524 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5853 | 0.010 |
Why?
|
| Health Surveys | 1 | 2004 | 4037 | 0.010 |
Why?
|
| Rural Population | 1 | 2004 | 2210 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 9648 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11366 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 12208 | 0.010 |
Why?
|